Middle Ear Neuroendocrine Tumor: A Case Report in Chaophrayayommarat Hospital
Keywords:
middle ear, middle ear tumer, neuroendocrine tumorAbstract
Neuroendocrine tumors are infrequent causes of middle ear masses. The pathogenesis is unclear due to the limitation of the small number of case reports. It has been reported with an average age of 50 years old with no gender difference. The most common presentation is unilateral conductive hearing loss. Other symptoms include ear fullness, tinnitus, and dizziness. Surgical resection provides good results for patients with these tumors. This study reported a female patient 37 years of age with left ear tumor. The tumor was partially removed and sent for tissue diagnosis. It showed middle ear neuroendocrine tumor combined with cholesteatoma in left mastoid. After that the patient was sent to a medical school for complete surgical resection.
References
Wenig B. Atlas of head and neck pathology. 3rd ed. Amsterdam: Elsevier; 2016.
Hyams VJ, Michaels L. Benign adenomatous neoplasm (adenoma) of the middle ear. Clin Otolaryngol Allied Sci 1976;1(1):17–26. doi:10.1111/j.1365-2273.1976.tb00637.x.
Bell D, El-Naggar AK, Gidley PW. Middle ear adenomatous neuroendocrine tumors: a 25-year experience at md anderson cancer center. Virchows Arch 2017;471(5):667–72. doi:10.1007/s00428-017-2155-6.
Ramsey MJ, Nadol JR, Pilch BZ, McKenna MJ. Carcinoid tumor of the middle ear: clinical features, recurrences, and metastases. Laryngoscope 2005;115(9):1660–6. doi:10.1097/01.mlg.0000175069.13685.37.
Pelosi S, Koss S. Adenomatous tumors of the middle ear. Otolaryngol Clin North Am 2015;48(2):305–15. doi:10.1016/j.otc.2014.12.005.
Torske KR, Thompson LD. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol 2002;15(5):543–55. doi:10.1038/modpathol.3880561.
El Naggar AK, Chan JKC, Takata T, et al. Who classification of the head and neck tumors. IARC Press;2017.
Saliba I, Evrard AS. Middle ear glandular neoplasm: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series. Cases Journal 2009;2:6508. doi:10.1186/1757-1626-0002-0000006508.
Katabi N. Neuroendocrine neoplasms of the ear. Head and Neck Pathology. 2018;12(3):362–6. doi:10.1007/s12105-018-0924-4.
Mete O, Wenig BM. Update from the 5th edition of the World Health Organization classification of Head and Neck Tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms. Head Neck Pathol. 2022;16(1):123–42. doi:10.1007/s12105-022-01435-8.
Bruschini L, Canelli R, Cambi C, et al. Middle ear neuroendocrine adenoma: a case report and literature review. Case Rep Otolaryngol. 2020. doi:10.1155/2020/8863188
Rahal PB, Wangberg B. Neuroendocrine adenoma of the middle ear—an intriguing entity. Clin Case Rep. 2021;9:1358–61. doi:10.1002/ccr3.3767.
Sukumaran Y, Pol Ong Y, Siow Ping L, Ong CA, Narayanan P. Cureus. Middle ear neuroendocrine tumor mimicking as chronic otitis media. 2023;15(7):e42296. doi: 10.7759/cureus.42296.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ลิขสิทธิ์บทความเป็นของผู้เขียนบทความ แต่หากผลงานของท่านได้รับการพิจารณาตีพิมพ์ลงวารสารแพทย์เขต 4-5 จะคงไว้ซึ่งสิทธิ์ในการตีพิมพ์ครั้งแรกด้วยเหตุที่บทความจะปรากฎในวารสารที่เข้าถึงได้ จึงอนุญาตให้นำบทความในวารสารไปใช้ประโยชน์ได้ในเชิงวิชาการโดยจำเป็นต้องมีการอ้างอิงถึงชื่อวารสารอย่างถูกต้อง แต่ไม่อนุญาตให้นำไปใช้ในเชิงพาณิชย์
